abbexa
SARS-CoV-2 Nucleoprotein CTD Domain | abx163975
- SKU:
- abx163975
- Availability:
- Usually shipped in 5 working days
Frequently bought together:
Description
SARS-CoV-2 Nucleoprotein CTD Domain. Cat# abx163975. Supplier: abbexa.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleoprotein CTD Domain is a recombinant protein expressed in E. coli.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
| Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleoprotein CTD Domain |
| Origin | Virus |
| Expression | Recombinant |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Host | E. coli |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Liquid |
| Purity | > 95% (SDS-PAGE) |
| Purification | 0.2 µm filtered. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| NCBI Accession | QHD43423.2 |
| Tag | N-terminal 6x His-tag. |
| Buffer | PBS, 2 M Urea, pH 7.4. |
| Endotoxin Level | < 0.1 ng/µg (1 IEU/µg) as determined by LAL test. |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. |